Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Diabetic peripheral neuropathy: an update on pathogenesis and management.

Literature DB >> 16469264

Diabetic peripheral neuropathy: an update on pathogenesis and management.

Betul M Gundogdu¹.

Abstract

Entities: Disease

Mesh：

Year: 2006 PMID： 16469264 DOI： 10.1007/s11910-996-0001-3

Source DB: PubMed Journal: Curr Neurol Neurosci Rep ISSN： 1528-4042 Impact factor: 5.081

× No keyword cloud information.

34 in total

1. The fusion of bone-marrow-derived proinsulin-expressing cells with nerve cells underlies diabetic neuropathy.

Authors: Tomoya Terashima; Hideto Kojima; Mineko Fujimiya; Kazuhiro Matsumura; Jiro Oi; Manami Hara; Atsunori Kashiwagi; Hiroshi Kimura; Hitoshi Yasuda; Lawrence Chan
Journal: Proc Natl Acad Sci U S A Date: 2005-08-22 Impact factor: 11.205

Review 2. Diabetic neuropathies: a statement by the American Diabetes Association.

Authors: Andrew J M Boulton; Arthur I Vinik; Joseph C Arezzo; Vera Bril; Eva L Feldman; Roy Freeman; Rayaz A Malik; Raelene E Maser; Jay M Sosenko; Dan Ziegler
Journal: Diabetes Care Date: 2005-04 Impact factor: 19.112

3. A double-blind placebo-controlled clinical trial of recombinant human brain-derived neurotrophic factor (rhBDNF) in diabetic polyneuropathy.

Authors: A Wellmer; V P Misra; M K Sharief; P G Kopelman; P Anand
Journal: J Peripher Nerv Syst Date: 2001-12 Impact factor: 3.494

4. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group.

Authors: S C Apfel; S Schwartz; B T Adornato; R Freeman; V Biton; M Rendell; A Vinik; M Giuliani; J C Stevens; R Barbano; P J Dyck
Journal: JAMA Date: 2000-11-01 Impact factor: 56.272

5. Improvement in chronic ischemic neuropathy after intramuscular phVEGF165 gene transfer in patients with critical limb ischemia.

Authors: D Simovic; J M Isner; A H Ropper; A Pieczek; D H Weinberg
Journal: Arch Neurol Date: 2001-05

6. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study.

Authors: P J Dyck; K M Kratz; J L Karnes; W J Litchy; R Klein; J M Pach; D M Wilson; P C O'Brien; L J Melton; F J Service
Journal: Neurology Date: 1993-04 Impact factor: 9.910

Diabetic peripheral neuropathy: an update on pathogenesis and management.

1. The fusion of bone-marrow-derived proinsulin-expressing cells with nerve cells underlies diabetic neuropathy.

Review 2. Diabetic neuropathies: a statement by the American Diabetes Association.

3. A double-blind placebo-controlled clinical trial of recombinant human brain-derived neurotrophic factor (rhBDNF) in diabetic polyneuropathy.

4. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group.

5. Improvement in chronic ischemic neuropathy after intramuscular phVEGF165 gene transfer in patients with critical limb ischemia.

6. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study.

7. Aldose reductase inhibition by AS-3201 in sural nerve from patients with diabetic sensorimotor polyneuropathy.

8. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial.

9. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy.

Review 10. Role of nitric oxide in matrix remodeling in diabetes and heart failure.

1. Beneficial effect of TNF-α inhibition on diabetic peripheral neuropathy.